Trek Financial’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Trek Financial's VRTX Position: Q2 2026 in Review
Trek Financial increased its Vertex Pharmaceuticals (VRTX) stake by 4.2% in Q2 2026, buying an estimated $11.5K and bringing the position to 646 shares worth $321K. The position accounts for 0.02% of the portfolio, ranked #397.
Trek Financial first reported a position in VRTX in Q4 2023 and has held it in 9 quarters since. The position peaked at $5.06M in Q4 2023. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Trek Financial held 646 shares of Vertex Pharmaceuticals worth $321K as of Q2 2026.
- Trek Financial bought 26 Vertex Pharmaceuticals shares in Q2 2026, an estimated $11.5K.
- Vertex Pharmaceuticals made up 0.02% of Trek Financial's portfolio in Q2 2026, its #397 holding.
- Trek Financial first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 9 quarters since.
- Trek Financial's Vertex Pharmaceuticals position peaked at $5.06M in Q4 2023.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Trek Financial's 13F filing for Q2 2026, filed 13 Aug 2026.